Clover Health Investments CLOV Income Statement (2019-2026)

NASDAQ CLOV
$4.10 -0.12 (-2.84%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
203.66M432.04M278.17M268.50M267.89M281.99M317.09M314.38M301.23M287.61M341.72M356.26M330.99M310.71M462.33M469.83M496.65M455.13M744.19M743.17M
Cost of Revenue (Quarter)
436.32M441.93M861.72M858.79M839.80M-1567.23M274.79M244.26M235.78M249.75M265.16M248.35M249.77M243.04M353.44M377.99M423.47M413.50M589.65M590.16M
Gross Profit (Quarter)
-232.67M-9.89M-583.55M-590.28M-571.91M1,849.22M42.30M70.12M65.44M37.86M76.56M107.91M81.21M67.67M108.89M91.83M73.18M41.63M154.54M153.00M
Operating items
Selling, General & Administrative (Quarter)
45.85M55.18M57.70M47.04M47.83M51.11M57.64M41.71M41.03M42.70M44.57M44.42M35.20M52.29M50.67M48.48M48.95M66.16M74.63M70.30M
Restructuring Costs (Quarter)
0.07M
Other Operating Expenses (Quarter)
530.57M563.65M904.16M902.39M883.08M-1510.16M344.05M307.31M298.61M332.81M325.06M304.65M304.57M306.12M412.93M439.69M472.07M470.87M647.23M644.87M
Operating Expenses (Quarter)
576.42M618.83M961.86M949.43M930.91M-1458.98M401.69M349.02M339.64M375.52M369.62M349.07M339.77M358.41M463.61M488.18M521.03M537.03M721.86M715.17M
Operating Income (Quarter)
-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M
EBIT (Quarter)
-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M
Non-operating items
Non Operating Investment Income (Quarter)
12.39M-1.23M-0.98M-0.97M-4.73M-0.47M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-149.66M-187.19M-135.08M-107.73M-74.50M-21.80M-587.20M-498.38M-38.12M-63.13M-25.48M4.87M-24.98M-21.45M-31.17M-25.76M-44.18M-49.61M26.43M-24.60M
Profit After Tax (Quarter)
-34.72M-188.53M-75.49M-104.36M-77.90M-84.23M-79.70M-28.81M-33.62M-70.47M-23.17M7.71M-9.15M-18.22M-1.27M-10.58M-24.38M-51.38M27.33M28.00M
Income from Non-Controlling Interests (Quarter)
-0.20M-1.32M-5.32M-1.09M-2.41M1.39M2.34M0.32M1.64M2.70M-0.19M0.30M3.11M-2.44M1.51M0.25M0.29M0.06M-1.20M-0.88M
Income from Continuing Operations (Quarter)
-149.66M-187.19M-135.08M-107.73M-74.50M-21.80M-587.20M-498.38M-38.12M-63.13M-25.48M4.87M-24.98M-21.45M-31.17M-25.76M-44.18M-49.61M26.43M-24.60M
Consolidated Net Income (Quarter)
-149.66M-187.19M-135.08M-107.73M-74.50M-21.80M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M-24.60M
Income towards Parent Company (Quarter)
-149.66M-187.19M-135.08M-107.73M-74.50M-21.80M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M-24.60M
Net Income towards Common Stockholders (Quarter)
-149.66M-187.19M-135.08M-107.73M-74.50M-21.80M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.40M-0.57M26.43M-24.60M
Additional items
EPS (Basic) (Quarter)
-0.36-0.45-0.29-0.23-0.16-0.050.010.00-0.02-0.010.010.000.000.000.05-0.05
EPS (Diluted) (Quarter)
-0.36-0.45-0.29-0.23-0.16-0.050.010.00-0.02-0.010.010.000.000.000.05-0.05
Shares Outstanding (Quarter)
414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M567.45M487.48M490.18M490.02M497.06M509.04M512.74M511.97M522.18M524.19M
Shares Outstanding (Diluted) (Quarter)
414.57M412.92M473.03M476.06M477.69M476.24M478.81M479.16M480.77M482.18M486.37M495.18M490.18M490.02M497.06M509.04M512.74M511.97M532.50M545.45M
Shares Outstanding (Entity) (Quarter)
414.57M470.85M473.30M477.40M383.53M384.00M394.13M395.77M399.37M401.18M567.45M406.49M411.26M414.49M414.16M418.39M421.82M426.67M429.56M433.43M
EBITDA (Quarter)
-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M28.00M
Interest Expenses (Quarter)
0.40M0.40M47.60M5.00M0.40M-0.56M507.50M469.50M4.50M2.78M2.32M16.20M29.90M15.20M19.80M0.29M0.90M52.60M